- Home
- DRVN vs VRDN Comparison
DRVN vs VRDN Comparison
Compare DRVN & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRVN | VRDN |
|---|---|---|
| Founded | 1972 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DRVN | VRDN |
|---|---|---|
| Price | $15.88 | $31.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $20.43 | ★ $41.17 |
| AVG Volume (30 Days) | 761.6K | ★ 1.5M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,439,296,000.00 | $70,789,000.00 |
| Revenue This Year | N/A | $26,257.62 |
| Revenue Next Year | $5.95 | $10.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.60 | ★ 23340.07 |
| 52 Week Low | $13.44 | $9.90 |
| 52 Week High | $19.74 | $34.04 |
Technical Indicators
Market Signals| Indicator | DRVN | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 61.53 | 54.36 |
| Support Level | $14.54 | $29.63 |
| Resistance Level | $15.02 | $31.47 |
| Average True Range (ATR) | 0.41 | 1.06 |
| MACD | 0.05 | -0.28 |
| Stochastic Oscillator | 97.29 | 64.62 |
Price Performance
Historical ComparisonAbout DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).